ISSN: 0975-0851
Statistical considerations in biosimilar assessment using biosimilarity index
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation
View More »
Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report
Commentary Article
A Complete Analysis and Side Effects of Generic Drugs
DOI: 10.35248/0975-0851.23.15.531
Evaluating Drug Action Dynamics by Using Pharmacokinetics
DOI: 10.35248/0975-0851.23.15.532
Perspective
Study of First-Pass Metabolism and its Uses
DOI: 10.35248/0975-0851.23.15.533
Understanding the Importance and Assessment of Bio Equivalence
DOI: 10.35248/0975-0851.23.15.534
Opinion Article
Using Therapeutic Equivalence to Provide Safety and Efficacy
DOI: 10.35248/0975-0851.23.15.535
Enhancing Oral Drug Absorption Rates Through Novel Formulation Strategies
DOI: 10.35248/0975-0851.23.15.536
The Role of Pharmacogenomics in Predicting Individual Pharmacological Responses
DOI: 10.35248/0975-0851.23.15.530
Commentry
Study of Relative Bioavailability in Pharmacology and Pharmaceutical Sciences
DOI: 10.35248/0975-0851.23.15.537
Research
An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Oral Bioequivalence Study of Femelle 20 (Drospirenone 3 Mg and Ethinyl Estradiol 0.02 Mg) Coated Tablets of Abbott and Yaz® (Drospirenone 3 Mg And Ethinyl Estradiol 0.02 Mg) Coated Tablets of Bayer in Healthy, Adult, Human Female Subjects Under Fasting Condition
DOI: 10.35248/0975-0851.23.15.528
An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan Medoxomil/Hydrochlorothiazide 40 mg/12.5 mg Coated Tablets of Abbott and Olmetec Plus® (Olmesartan Medoxomil/Hydrochlorothiazide) 40 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition
DOI: 10.35248/0975-0851.23.15.529